Cardiac Amyloidosis

Dr. Rodney H. Falk is the Director of the Cardiac Amyloidosis Program and a cardiovascular medicine specialist at Brigham and Women's Hospital (BWH). He is also an…

Stephen Heitner, MD

Stephen Heitner is a Senior Medical Director at Cytokinetics. Previously he worked as a Cardiologist at Oregon Health & Science University (OHSU). He received…

Martha Grogan, MD

Martha Grogan is a Cardiologist-Internist at Mayo Clinicexternal link, opens in a new tab, Rochester, Minnesota. She completed her graduation with distinction in…

ESC: Tafamidis Cuts Deaths, Admissions in TTR Cardiac Amyloidosis

Why There’s New Hope if You Have Cardiac Amyloidosis

Major Advances are Afoot in Management of ATTR Cardiac Amyloidosis

Cardiac amyloidosis, traditionally considered a rare and dire disease, is receiving increasing attention as sophisticated diagnostics are identifying more patients…

Resurrecting Tc 99m PYP: As Cardiac Amyloidosis Therapies Emerge, an Old Test Gains a New Purpose

Once used to diagnose myocardial infarction, technetium-99m pyrophosphate (Tc 99m PYP) imaging may be reborn as an alternative to biopsy for diagnosing cardiac…

Standardization of 99m technetium Pyrophosphate Imaging Methodology to Diagnose TTR Cardiac Amyloidosis

@rodney_falk

Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.

@BWHAmyloid

The official Twitter for the Brigham and Women's Hospital Amyloidosis Program.

Subscribe to